A significant advance in cancer research is emerging with the use of VHH fragments to reactivate dysfunctional p53. This crucial cancer inhibitor protein is frequently disabled in many kinds of malignancies, resulting https://bookmarkvids.com/story440985/vhh-fragments-revive-p53-new-promising-approach-for-tumor-management